Detailing Clinical Development of OncoFAP: a Small Molecule Conjugate Targeting Fibroblast Activation Protein in Solid Tumours
Time: 9:30 am
day: Conference Day Two pt 1
Details:
• Exploring ongoing OncoFAP tumour target activity in first-in-human imaging studies in solid tumours
• Assessing OncoFAP anti-tumour response as a monotherapy and in combination with immunotherapies
• Contrasting anti-cancer properties of small-molecule conjugates against antibody-drug conjugates
